Entresto Pill

DRUG2 trials

Sponsors

Jacob Moller, Mayo Clinic

Conditions

Congenital Heart DiseaseDiastolic DysfunctionMyocardial Infarction

Phase 2

Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI

TerminatedNCT04149990

Jacob MollerDiastolic Dysfunction, Myocardial Infarction

Start: 2018-10-12End: 2023-06-06Updated: 2025-01-29

Phase 3

Effect of Sacubitril-Valsartan on Cardiac Structure and Function

RecruitingNCT06693674

Mayo ClinicCongenital Heart Disease

Start: 2025-02-03End: 2026-12-31Target: 45Updated: 2025-10-07